NEWS

Director, Dr. Masashi Yanagisawa Receives “Breakthrough Prize”

Potential New Treatment for Angioimmunoblastic T-cell Lymphoma Revealed

When More Is More: Identifying Cognitive Impairments with Multiple Drawing Tasks

Information of admission examination (April/October 2023 enrollment)